Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market

Go back to Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market
(NASDAQ: CMND) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High
Open $0.82    52 Week Low
Day High $1.06    P/E N/A 
Day Low $0.81    EPS
Volume 9,552